Skip to main content

Table 2 Demographics and baseline characteristics (treated set)

From: The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study

Randomised volunteers, n

30

   Male gender, n (%)

16 (53.3)

   Number completing study, n (%)

27 (90.0)

Baseline characteristics

Median (range)

   Age (years)

32.5 (18−52)

   Height (cm)

170.5 (161−184)

   Weight (kg)

68.0 (52−88)

   BMI (kg/m2)

23.2 (19.1−28.4)

   Heart rate (bpm)

56.0 (42.0−75.0)

   QT interval (ms)

403.5 (363.0−475.0)

   QTcN interval (ms)

399.0 (372.5−440.3)

  1. BMI, body mass index; bpm, beats per minute; QTcN, population heart rate-corrected QT interval.